Not Yet Recruiting PHASE4 INTERVENTIONAL 2-arm
NCT06856772
Randomized Comparison of Morning Versus Bedtime Administration of Statins: A Cardiovascular Circadian Chronotherapy (C3) Trial (STATIN-C3)
Sponsor: Herlev and Gentofte Hospital
Interventions
Statin in the evening (such as Simvastatin, Atorvastatin, Rosuvastatin, Pravastatin) Statin in the morning (such as Simvastatin, Atorvastatin, Rosuvastatin, Pravastatin)
Updated 2 times since 2025 Last updated: Feb 26, 2025 Started: Feb 28, 2025 Primary completion: Mar 28, 2028 Completion: Mar 28, 2028
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT06856772, this PHASE4 trial focuses on Atherosclerosis Cardiovascular Disease and Cardiovascular Diseases (CVD) and remains actively recruiting participants. Sponsored by Herlev and Gentofte Hospital, it has been updated 2 times since 2025, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
2 versions recorded-
Jun 2025 — Present [monthly]
Not Yet Recruiting PHASE4
-
Apr 2025 — Jun 2025 [monthly]
Not Yet Recruiting PHASE4
First recorded
Feb 2025
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Herlev and Gentofte Hospital
- Tor Biering-Sørensen
Data source: Herlev and Gentofte Hospital
For direct contact, visit the study record on ClinicalTrials.gov .